We are a biopharmaceutical company and manufacturer of cell transplants. Our focus is on the development, manufacturing and marketing of autologous cell therapies for the joint-preserving treatment of articular cartilage defects. Our more than 100 employees come from many different professional backgrounds - scientists, researchers, manufacturing and quality control specialists, engineers, experts for regulatory affairs, clinical trials, market access, communication and many other areas. Hand in hand, they ensure the highest product quality - for the benefit of patients and our customers. More than 16,000 patients have been treated with CO.DON products.
